Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Colorcon
Farmers Insurance
Argus Health
Boehringer Ingelheim
Covington
Queensland Health
Cerilliant
AstraZeneca

Generated: June 23, 2018

DrugPatentWatch Database Preview

DROLBAN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Drolban patents expire, and when can generic versions of Drolban launch?

Drolban is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in DROLBAN is dromostanolone propionate. There is one drug master file entry for this compound. Additional details are available on the dromostanolone propionate profile page.
Summary for DROLBAN
Drug patent expirations by year for DROLBAN
Synonyms for DROLBAN
(1S,2S,4R,7S,10R,11S,14S,15S)-2,4,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-14-YL PROPANOATE
(1S,2S,4R,7S,10R,11S,14S,15S)-2,4,15-trimethyl-5-oxotetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadecan-14-yl propanoate
(2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate
[(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxidanylidene-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
[(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
1334-53-8
17.beta.-Hydroxy-2.alpha.-methyl-5.alpha.-androstan-3-one propionate
17b-hydroxy-2a-methyl-5a-androstan-3-one propionate
17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one propionate
2-Methyl-3-oxoandrostan-17-yl propionate, (2.alpha.,5.alpha.,17.beta.)- #
2.alpha.-Methyl-4,5-dihydrotestosterone propionate
2.alpha.-Methyldihydrotestosterone propionate
2alpha-methyl-3-oxo-5alpha-androstan-17beta-yl propanoate
2alpha-Methyl-4,5-dihydrotestosterone propionate
2M-DHTP
2MDTP
4-08-00-00654 (Beilstein Handbook Reference)
5-alpha-Androstan-3-one, 17-beta-hydroxy-2-alpha-methyl-, propionate
5.alpha.-Androstan-3-one, 17.beta.-hydroxy-2.alpha.-methyl-, propionate
51258-12-9
521-12-0
521D120
A828929
AC1L5CZ4
ACN-031995
AI3-52810
AJ-48950
AK115035
AKOS015895157
Androstan-3-one, 17-hydroxy-2-methyl-, (2alpha,5alpha,17beta)-(9CI)
Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-
Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2.alpha.,5.alpha.,17.beta.)-
Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2a,5a,17b)-
Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2alpha,5alpha,17beta)-
Androstan-3-one,2-methyl-17-(1-oxopropoxy)-,(2|A,5|A,17|A)-
Blackburn Compound
BRN 3161958
CHEBI:31523
CHEMBL1201048
D01534
D09NNA
Drolban (TN)
Dromostanolone 17-propionate
DROMOSTANOLONE PROPIONATE
Dromostanolone propionate (USAN)
Dromostanolone propionate [USAN:USP]
Dromostanolone proprionate
drostanolone propionate
Drostanolone propionate (JAN)
DTXSID1022972
EINECS 208-303-1
Emdisterone
GTPL6947
KB-294891
Lilly 32379
Masterid
Masteril
Masteron
Masteron (TN)
Masterone
MDHT
Medrotestron propionate
Medrotestrone propanoate
Medrotestrone propionate
MFCD01669961
Nomasteron
NOTIQUSPUUHHEH-UXOVVSIBSA-N
NSC-12198
NSC-1298
NSC12198
Permastril
PL000296
prometholone
propanoic acid [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] ester
Re 346
RS 1567
SC-16209
SCHEMBL3173
Testosterone, 4,5.alpha.-dihydro-2.alpha.-methyl-, propionate
Testosterone, 4,5alpha-dihydro-2alpha-methyl-, propionate
Testosterone,5.alpha.-dihydro-2.alpha.-methyl-, propionate
UNII-X20UZ57G4O
W-105852
X20UZ57G4O
ZINC4213057

US Patents and Regulatory Information for DROLBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DROLBAN dromostanolone propionate INJECTABLE;INJECTION 012936-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Argus Health
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission
US Army
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.